Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selumetinib +/- Temsirolimus in Soft-Tissue Sarcoma
NCT01206140Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2010
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selumetinib in soft tissue sarcoma (STS), sponsored by National Cancer Institute. Started Oct 2010; status: completed.
02
Drugs
selumetinib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01206140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01206140.